CAM
ABBV icon

Crestone Asset Management’s AbbVie ABBV Stock Holding History

Crestone Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,235
Closed -$225K – 2
2024
Q1 		$225K Buy
+1,235
New +$213K 0.05% 88
2022
Q3 		– Sell
-1,448
Closed -$222K – 72
2022
Q2 		$222K Hold
1,448
– – 0.05% 78
2022
Q1 		$235K Buy
+1,448
New +$210K 0.05% 77

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Crestone Asset Management's ABBV Position: Q2 2024 in Review

Crestone Asset Management sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 1,235 shares — an estimated $225K sold.

Crestone Asset Management first reported a position in ABBV in Q1 2022 and held it in 3 quarters. The position peaked at $235K in Q1 2022. 3,364 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Crestone Asset Management reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • Crestone Asset Management sold 1,235 AbbVie shares in Q2 2024, an estimated $225K.
  • Crestone Asset Management first reported a position in AbbVie in Q1 2022 and held it in 3 quarters.
  • Crestone Asset Management's AbbVie position peaked at $235K in Q1 2022.
  • 3,364 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Crestone Asset Management's 13F filing for Q2 2024.